Serveur d'exploration sur la rapamycine et les champignons

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy.

Identifieur interne : 000683 ( Main/Exploration ); précédent : 000682; suivant : 000684

mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy.

Auteurs : Kara N. Goldman [États-Unis] ; Devon Chenette [États-Unis] ; Rezina Arju [États-Unis] ; Francesca E. Duncan [États-Unis] ; David L. Keefe [États-Unis] ; Jamie A. Grifo [États-Unis] ; Robert J. Schneider [États-Unis]

Source :

RBID : pubmed:28270607

Descripteurs français

English descriptors

Abstract

The ovary contains oocytes within immature (primordial) follicles that are fixed in number at birth. Activation of follicles within this fixed pool causes an irreversible decline in reproductive capacity, known as the ovarian reserve, until menopause. Premenopausal women undergoing commonly used genotoxic (DNA-damaging) chemotherapy experience an accelerated loss of the ovarian reserve, leading to subfertility and infertility. Therefore, there is considerable interest but little effective progress in preserving ovarian function during chemotherapy. Here we show that blocking the kinase mammalian/mechanistic target of rapamycin (mTOR) with clinically available small-molecule inhibitors preserves ovarian function and fertility during chemotherapy. Using a clinically relevant mouse model of chemotherapy-induced gonadotoxicity by cyclophosphamide, and inhibition of mTOR complex 1 (mTORC1) with the clinically approved drug everolimus (RAD001) or inhibition of mTORC1/2 with the experimental drug INK128, we show that mTOR inhibition preserves the ovarian reserve, primordial follicle counts, serum anti-Mullerian hormone levels (a rigorous measure of the ovarian reserve), and fertility. Chemotherapy-treated animals had significantly fewer offspring compared with all other treatment groups, whereas cotreatment with mTOR inhibitors preserved normal fertility. Inhibition of mTORC1 or mTORC1/2 within ovaries was achieved during chemotherapy cotreatment, concomitant with preservation of primordial follicle counts. Importantly, our findings indicate that as little as a two- to fourfold reduction in mTOR activity preserves ovarian function and normal birth numbers. As everolimus is approved for tamoxifen-resistant or relapsing estrogen receptor-positive breast cancer, these findings represent a potentially effective and readily accessible pharmacologic approach to fertility preservation during conventional chemotherapy.

DOI: 10.1073/pnas.1617233114
PubMed: 28270607
PubMed Central: PMC5373380


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy.</title>
<author>
<name sortKey="Goldman, Kara N" sort="Goldman, Kara N" uniqKey="Goldman K" first="Kara N" last="Goldman">Kara N. Goldman</name>
<affiliation wicri:level="2">
<nlm:affiliation>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, New York University School of Medicine, New York</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Chenette, Devon" sort="Chenette, Devon" uniqKey="Chenette D" first="Devon" last="Chenette">Devon Chenette</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Microbiology, New York University School of Medicine, New York, NY 10016.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Microbiology, New York University School of Medicine, New York</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Arju, Rezina" sort="Arju, Rezina" uniqKey="Arju R" first="Rezina" last="Arju">Rezina Arju</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Microbiology, New York University School of Medicine, New York, NY 10016.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Microbiology, New York University School of Medicine, New York</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Duncan, Francesca E" sort="Duncan, Francesca E" uniqKey="Duncan F" first="Francesca E" last="Duncan">Francesca E. Duncan</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Illinois</region>
</placeName>
<wicri:cityArea>Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Keefe, David L" sort="Keefe, David L" uniqKey="Keefe D" first="David L" last="Keefe">David L. Keefe</name>
<affiliation wicri:level="2">
<nlm:affiliation>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, New York University School of Medicine, New York</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Grifo, Jamie A" sort="Grifo, Jamie A" uniqKey="Grifo J" first="Jamie A" last="Grifo">Jamie A. Grifo</name>
<affiliation wicri:level="2">
<nlm:affiliation>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, New York University School of Medicine, New York</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Schneider, Robert J" sort="Schneider, Robert J" uniqKey="Schneider R" first="Robert J" last="Schneider">Robert J. Schneider</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Microbiology, New York University School of Medicine, New York, NY 10016; robert.schneider@nyumc.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Microbiology, New York University School of Medicine, New York</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<nlm:affiliation>Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Perlmutter Cancer Center, New York University School of Medicine, New York</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28270607</idno>
<idno type="pmid">28270607</idno>
<idno type="doi">10.1073/pnas.1617233114</idno>
<idno type="pmc">PMC5373380</idno>
<idno type="wicri:Area/Main/Corpus">000857</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000857</idno>
<idno type="wicri:Area/Main/Curation">000857</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000857</idno>
<idno type="wicri:Area/Main/Exploration">000857</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy.</title>
<author>
<name sortKey="Goldman, Kara N" sort="Goldman, Kara N" uniqKey="Goldman K" first="Kara N" last="Goldman">Kara N. Goldman</name>
<affiliation wicri:level="2">
<nlm:affiliation>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, New York University School of Medicine, New York</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Chenette, Devon" sort="Chenette, Devon" uniqKey="Chenette D" first="Devon" last="Chenette">Devon Chenette</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Microbiology, New York University School of Medicine, New York, NY 10016.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Microbiology, New York University School of Medicine, New York</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Arju, Rezina" sort="Arju, Rezina" uniqKey="Arju R" first="Rezina" last="Arju">Rezina Arju</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Microbiology, New York University School of Medicine, New York, NY 10016.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Microbiology, New York University School of Medicine, New York</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Duncan, Francesca E" sort="Duncan, Francesca E" uniqKey="Duncan F" first="Francesca E" last="Duncan">Francesca E. Duncan</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Illinois</region>
</placeName>
<wicri:cityArea>Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Keefe, David L" sort="Keefe, David L" uniqKey="Keefe D" first="David L" last="Keefe">David L. Keefe</name>
<affiliation wicri:level="2">
<nlm:affiliation>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, New York University School of Medicine, New York</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Grifo, Jamie A" sort="Grifo, Jamie A" uniqKey="Grifo J" first="Jamie A" last="Grifo">Jamie A. Grifo</name>
<affiliation wicri:level="2">
<nlm:affiliation>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, New York University School of Medicine, New York</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Schneider, Robert J" sort="Schneider, Robert J" uniqKey="Schneider R" first="Robert J" last="Schneider">Robert J. Schneider</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Microbiology, New York University School of Medicine, New York, NY 10016; robert.schneider@nyumc.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Microbiology, New York University School of Medicine, New York</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<nlm:affiliation>Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Perlmutter Cancer Center, New York University School of Medicine, New York</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Proceedings of the National Academy of Sciences of the United States of America</title>
<idno type="eISSN">1091-6490</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals (MeSH)</term>
<term>Anti-Mullerian Hormone (blood)</term>
<term>Antineoplastic Agents (adverse effects)</term>
<term>Antineoplastic Agents (pharmacology)</term>
<term>Biomarkers (MeSH)</term>
<term>Disease Models, Animal (MeSH)</term>
<term>Dose-Response Relationship, Drug (MeSH)</term>
<term>Female (MeSH)</term>
<term>Fertility Preservation (MeSH)</term>
<term>Immunohistochemistry (MeSH)</term>
<term>Mechanistic Target of Rapamycin Complex 1 (antagonists & inhibitors)</term>
<term>Mechanistic Target of Rapamycin Complex 1 (metabolism)</term>
<term>Mechanistic Target of Rapamycin Complex 2 (antagonists & inhibitors)</term>
<term>Mechanistic Target of Rapamycin Complex 2 (metabolism)</term>
<term>Mice (MeSH)</term>
<term>Ovarian Follicle (drug effects)</term>
<term>Ovarian Follicle (metabolism)</term>
<term>Ovary (drug effects)</term>
<term>Ovary (physiology)</term>
<term>Protein Kinase Inhibitors (pharmacology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux (MeSH)</term>
<term>Antinéoplasiques (effets indésirables)</term>
<term>Antinéoplasiques (pharmacologie)</term>
<term>Complexe-1 cible mécanistique de la rapamycine (antagonistes et inhibiteurs)</term>
<term>Complexe-1 cible mécanistique de la rapamycine (métabolisme)</term>
<term>Complexe-2 cible mécanistique de la rapamycine (antagonistes et inhibiteurs)</term>
<term>Complexe-2 cible mécanistique de la rapamycine (métabolisme)</term>
<term>Femelle (MeSH)</term>
<term>Follicule ovarique (effets des médicaments et des substances chimiques)</term>
<term>Follicule ovarique (métabolisme)</term>
<term>Hormone antimullérienne (sang)</term>
<term>Immunohistochimie (MeSH)</term>
<term>Inhibiteurs de protéines kinases (pharmacologie)</term>
<term>Marqueurs biologiques (MeSH)</term>
<term>Modèles animaux de maladie humaine (MeSH)</term>
<term>Ovaire (effets des médicaments et des substances chimiques)</term>
<term>Ovaire (physiologie)</term>
<term>Préservation de la fertilité (MeSH)</term>
<term>Relation dose-effet des médicaments (MeSH)</term>
<term>Souris (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Antineoplastic Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Mechanistic Target of Rapamycin Complex 1</term>
<term>Mechanistic Target of Rapamycin Complex 2</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Anti-Mullerian Hormone</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Mechanistic Target of Rapamycin Complex 1</term>
<term>Mechanistic Target of Rapamycin Complex 2</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Antineoplastic Agents</term>
<term>Protein Kinase Inhibitors</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Complexe-1 cible mécanistique de la rapamycine</term>
<term>Complexe-2 cible mécanistique de la rapamycine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Ovarian Follicle</term>
<term>Ovary</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr">
<term>Follicule ovarique</term>
<term>Ovaire</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Antinéoplasiques</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Ovarian Follicle</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Complexe-1 cible mécanistique de la rapamycine</term>
<term>Complexe-2 cible mécanistique de la rapamycine</term>
<term>Follicule ovarique</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Antinéoplasiques</term>
<term>Inhibiteurs de protéines kinases</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Ovaire</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Ovary</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>Hormone antimullérienne</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Biomarkers</term>
<term>Disease Models, Animal</term>
<term>Dose-Response Relationship, Drug</term>
<term>Female</term>
<term>Fertility Preservation</term>
<term>Immunohistochemistry</term>
<term>Mice</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Femelle</term>
<term>Immunohistochimie</term>
<term>Marqueurs biologiques</term>
<term>Modèles animaux de maladie humaine</term>
<term>Préservation de la fertilité</term>
<term>Relation dose-effet des médicaments</term>
<term>Souris</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The ovary contains oocytes within immature (primordial) follicles that are fixed in number at birth. Activation of follicles within this fixed pool causes an irreversible decline in reproductive capacity, known as the ovarian reserve, until menopause. Premenopausal women undergoing commonly used genotoxic (DNA-damaging) chemotherapy experience an accelerated loss of the ovarian reserve, leading to subfertility and infertility. Therefore, there is considerable interest but little effective progress in preserving ovarian function during chemotherapy. Here we show that blocking the kinase mammalian/mechanistic target of rapamycin (mTOR) with clinically available small-molecule inhibitors preserves ovarian function and fertility during chemotherapy. Using a clinically relevant mouse model of chemotherapy-induced gonadotoxicity by cyclophosphamide, and inhibition of mTOR complex 1 (mTORC1) with the clinically approved drug everolimus (RAD001) or inhibition of mTORC1/2 with the experimental drug INK128, we show that mTOR inhibition preserves the ovarian reserve, primordial follicle counts, serum anti-Mullerian hormone levels (a rigorous measure of the ovarian reserve), and fertility. Chemotherapy-treated animals had significantly fewer offspring compared with all other treatment groups, whereas cotreatment with mTOR inhibitors preserved normal fertility. Inhibition of mTORC1 or mTORC1/2 within ovaries was achieved during chemotherapy cotreatment, concomitant with preservation of primordial follicle counts. Importantly, our findings indicate that as little as a two- to fourfold reduction in mTOR activity preserves ovarian function and normal birth numbers. As everolimus is approved for tamoxifen-resistant or relapsing estrogen receptor-positive breast cancer, these findings represent a potentially effective and readily accessible pharmacologic approach to fertility preservation during conventional chemotherapy.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">28270607</PMID>
<DateCompleted>
<Year>2018</Year>
<Month>04</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1091-6490</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>114</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2017</Year>
<Month>03</Month>
<Day>21</Day>
</PubDate>
</JournalIssue>
<Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
<ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation>
</Journal>
<ArticleTitle>mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy.</ArticleTitle>
<Pagination>
<MedlinePgn>3186-3191</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1617233114</ELocationID>
<Abstract>
<AbstractText>The ovary contains oocytes within immature (primordial) follicles that are fixed in number at birth. Activation of follicles within this fixed pool causes an irreversible decline in reproductive capacity, known as the ovarian reserve, until menopause. Premenopausal women undergoing commonly used genotoxic (DNA-damaging) chemotherapy experience an accelerated loss of the ovarian reserve, leading to subfertility and infertility. Therefore, there is considerable interest but little effective progress in preserving ovarian function during chemotherapy. Here we show that blocking the kinase mammalian/mechanistic target of rapamycin (mTOR) with clinically available small-molecule inhibitors preserves ovarian function and fertility during chemotherapy. Using a clinically relevant mouse model of chemotherapy-induced gonadotoxicity by cyclophosphamide, and inhibition of mTOR complex 1 (mTORC1) with the clinically approved drug everolimus (RAD001) or inhibition of mTORC1/2 with the experimental drug INK128, we show that mTOR inhibition preserves the ovarian reserve, primordial follicle counts, serum anti-Mullerian hormone levels (a rigorous measure of the ovarian reserve), and fertility. Chemotherapy-treated animals had significantly fewer offspring compared with all other treatment groups, whereas cotreatment with mTOR inhibitors preserved normal fertility. Inhibition of mTORC1 or mTORC1/2 within ovaries was achieved during chemotherapy cotreatment, concomitant with preservation of primordial follicle counts. Importantly, our findings indicate that as little as a two- to fourfold reduction in mTOR activity preserves ovarian function and normal birth numbers. As everolimus is approved for tamoxifen-resistant or relapsing estrogen receptor-positive breast cancer, these findings represent a potentially effective and readily accessible pharmacologic approach to fertility preservation during conventional chemotherapy.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Goldman</LastName>
<ForeName>Kara N</ForeName>
<Initials>KN</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chenette</LastName>
<ForeName>Devon</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology, New York University School of Medicine, New York, NY 10016.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arju</LastName>
<ForeName>Rezina</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology, New York University School of Medicine, New York, NY 10016.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Duncan</LastName>
<ForeName>Francesca E</ForeName>
<Initials>FE</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Keefe</LastName>
<ForeName>David L</ForeName>
<Initials>DL</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Grifo</LastName>
<ForeName>Jamie A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schneider</LastName>
<ForeName>Robert J</ForeName>
<Initials>RJ</Initials>
<Identifier Source="ORCID">0000-0001-5807-5564</Identifier>
<AffiliationInfo>
<Affiliation>Department of Microbiology, New York University School of Medicine, New York, NY 10016; robert.schneider@nyumc.org.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 CA016087</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P50 HD076188</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2017</Year>
<Month>03</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
<NlmUniqueID>7505876</NlmUniqueID>
<ISSNLinking>0027-8424</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>80497-65-0</RegistryNumber>
<NameOfSubstance UI="D054304">Anti-Mullerian Hormone</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D000076222">Mechanistic Target of Rapamycin Complex 1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D000076225">Mechanistic Target of Rapamycin Complex 2</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054304" MajorTopicYN="N">Anti-Mullerian Hormone</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D059247" MajorTopicYN="Y">Fertility Preservation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000076222" MajorTopicYN="N">Mechanistic Target of Rapamycin Complex 1</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000076225" MajorTopicYN="N">Mechanistic Target of Rapamycin Complex 2</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006080" MajorTopicYN="N">Ovarian Follicle</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010053" MajorTopicYN="N">Ovary</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D047428" MajorTopicYN="N">Protein Kinase Inhibitors</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">chemotherapy</Keyword>
<Keyword MajorTopicYN="Y">fertility</Keyword>
<Keyword MajorTopicYN="Y">mTOR</Keyword>
<Keyword MajorTopicYN="Y">ovarian function</Keyword>
<Keyword MajorTopicYN="Y">ovary</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>3</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2018</Year>
<Month>4</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>3</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">28270607</ArticleId>
<ArticleId IdType="pii">1617233114</ArticleId>
<ArticleId IdType="doi">10.1073/pnas.1617233114</ArticleId>
<ArticleId IdType="pmc">PMC5373380</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Int Urol Nephrol. 2010 Jun;42(2):493-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19774480</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Fertil Steril. 2011 Jan;95(1):170-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20522327</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Breast Cancer Res Treat. 2012 Dec;136(3):673-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23085766</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Semin Reprod Med. 2011 Jul;29(4):353-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21969269</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Cycle. 2015;14(5):721-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25590233</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Hum Reprod. 2009 Dec;15(12):765-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19843635</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Fertil Steril. 2013 May;99(6):1558-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23461824</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Transplant. 2007 Oct;7(10):2414-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17845575</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Obstet Gynecol. 2011 Jul;118(1):63-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21691164</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Reprod Toxicol. 1991;5(4):379-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1806143</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Reprod. 2002 Dec;17 (12 ):3065-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12456604</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2015 Mar 5;372(10):923-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25738668</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Reprod. 2015 Mar;30(3):608-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25567618</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cancer Ther. 2015 May;14(5):1224-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25724664</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Obstet Gynecol. 2010 Dec;53(4):727-39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21048440</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Breast Cancer Res Treat. 2013 Aug;140(3):453-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23907751</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Discov Today Ther Strateg. 2009 Summer;6(2):47-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20622997</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Transplantation. 2012 May 15;93(9):874-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22357177</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2005 Feb 18;307(5712):1098-101</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15718470</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Transl Med. 2013 May 15;5(185):185ra62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23677591</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2008 Feb 1;319(5863):611-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18239123</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Natl Vital Stat Rep. 2013 Dec 30;62(9):1-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25671704</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Reprod Fertil. 1968 Dec;17(3):555-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">5715685</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Fertil Steril. 2014 May;101(5):1237-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24684955</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Reprod Update. 2011 Nov-Dec;17(6):848-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21652599</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 1996 Mar 16;347(9003):714-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8602000</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Reprod Toxicol. 1991;5(6):481-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1810575</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Ovarian Res. 2014 Oct 21;7:97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25330910</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Obstet Gynecol. 2014 Mar;123(3):719-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24553169</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Reprod Update. 2016 Apr;22(3):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26740585</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Reprod Sci. 2015 Jan;22(1):60-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25001019</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Menopause. 2015 Feb;22(2):166-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25003622</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Reproduction. 2006 Jul;132(1):95-109</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16816336</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pancreas. 2014 Jan;43(1):88-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24263107</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2015 Dec 14;10 (12 ):e0144245</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26656301</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Endocrinol (Copenh). 1969 Sep;62(1):98-116</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">5394354</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Reprod. 2008 Jan;23(1):178-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18024486</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17474-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24082083</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Fertil Steril. 2014 Apr;101(4):1031-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24502890</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Oncol. 2008 May;32(5):991-1000</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18425325</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2006 Feb 10;124(3):471-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16469695</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Reprod. 1994 Feb;50(2):225-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8142540</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10280-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20479243</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Aging (Albany NY). 2011 Aug;3(8):782-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21869459</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2890-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11867735</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Mol Genet. 2010 Feb 1;19(3):397-410</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19843540</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2015 Mar 6;290(10):6387-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25564616</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gerontol A Biol Sci Med Sci. 2015 May;70(5):577-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25038772</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2010 Sep 11;376(9744):911-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20708256</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Biol. 2014 Nov 3;24(21):2501-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25438940</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Breast. 2013 Apr;22(2):150-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23298851</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Reprod Update. 2014 May-Jun;20(3):370-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24430863</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Reprod. 2008 Feb;23(2):324-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18077317</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocr Rev. 2000 Apr;21(2):200-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10782364</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Metabolism. 2014 Jan;63(1):94-103</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24135502</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Pharmacokinet. 2004;43(2):83-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14748618</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Reprod Sci. 2015 Apr;22(4):442-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25031316</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Illinois</li>
<li>État de New York</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="État de New York">
<name sortKey="Goldman, Kara N" sort="Goldman, Kara N" uniqKey="Goldman K" first="Kara N" last="Goldman">Kara N. Goldman</name>
</region>
<name sortKey="Arju, Rezina" sort="Arju, Rezina" uniqKey="Arju R" first="Rezina" last="Arju">Rezina Arju</name>
<name sortKey="Chenette, Devon" sort="Chenette, Devon" uniqKey="Chenette D" first="Devon" last="Chenette">Devon Chenette</name>
<name sortKey="Duncan, Francesca E" sort="Duncan, Francesca E" uniqKey="Duncan F" first="Francesca E" last="Duncan">Francesca E. Duncan</name>
<name sortKey="Grifo, Jamie A" sort="Grifo, Jamie A" uniqKey="Grifo J" first="Jamie A" last="Grifo">Jamie A. Grifo</name>
<name sortKey="Keefe, David L" sort="Keefe, David L" uniqKey="Keefe D" first="David L" last="Keefe">David L. Keefe</name>
<name sortKey="Schneider, Robert J" sort="Schneider, Robert J" uniqKey="Schneider R" first="Robert J" last="Schneider">Robert J. Schneider</name>
<name sortKey="Schneider, Robert J" sort="Schneider, Robert J" uniqKey="Schneider R" first="Robert J" last="Schneider">Robert J. Schneider</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000683 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000683 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:28270607
   |texte=   mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:28270607" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020